Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-710-0 | CAS number: 109-83-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 Jun 1965 - 20 Jul 1965
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Acceptable, well-documented report which meets basic scientific principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 965
- Report date:
- 1965
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- BASF-Test
- Principles of method if other than guideline:
- BASF-Test. See further details in remarks on materials and methods.
- GLP compliance:
- no
- Test type:
- standard acute method
Test material
- Reference substance name:
- 2-methylaminoethanol
- EC Number:
- 203-710-0
- EC Name:
- 2-methylaminoethanol
- Cas Number:
- 109-83-1
- Molecular formula:
- C3H9NO
- IUPAC Name:
- 2-(methylamino)ethan-1-ol
- Details on test material:
- - Name of test material (as cited in study report): Monomethylaethanolamin
- Analytical purity: 99-100 %
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: US-rats
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: males: 148 - 230 g; females: 112 - 150 g
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 0.5, 2, 8, 16, 20 % - Doses:
- 25, 200, 800, 1600, 2000, 2500 and 3200 µl/kg bw (23.5, 188, 752, 1504, 1880, 2350 and 3008 mg/kg bw - conversation into mg/kg bw is based on the density: d=0.94 g/cm3)
- No. of animals per sex per dose:
- 5
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 1 880 mg/kg bw
- Based on:
- act. ingr.
- Remarks on result:
- other: conversion in mg/kg is based on the density: d=0.94 g/cm3
- Mortality:
- See details in remarks on results.
- Clinical signs:
- other: 3008 mg/kg bw: abdominal position, irregular, accelerated respiration, staggering, calm behavior, chewing compulsions. 2350 mg/kg bw: calm behavior, staggering, chewing compulsions, gasping, dyspnoea. After 24 h squatting posture, ruffled fur, irregular r
- Gross pathology:
- 3008 mg/kg bw: 1 x intestinal atony.
1880 mg/kg bw: 1 animal with distended ulceration with phlegmone and abscess of the entire glandular stomach. 1 x intestinal irritation.
Any other information on results incl. tables
Mortality:
Dose (mg/kg bw) | Gender | conc. % | 1 h | 24 h | 48h | day 7 | day 14 |
3008 | male | 20 | 0/5 | 5/5 | 5/5 | 5/5 | 5/5 |
3008 | female | 20 | 0/5 | 4/5 | 5/5 | 5/5 | 5/5 |
2350 | male | 20 | 0/5 | 2/5 | 3/5 | 3/5 | 3/5 |
2350 | female | 20 | 0/5 | 4/5 | 5/5 | 5/5 | 5/5 |
1880 | male | 20 | 0/5 | 1/5 | 1/5 | 1/5 | 2/5 |
1880 | female | 20 | 0/5 | 1/5 | 1/5 | 4/5 | 4/5 |
1504 | male | 16 | 0/5 | 1/5 | 1/5 | 1/5 | 1/5 |
1504 | female | 16 | 0/5 | 1/5 | 1/5 | 1/5 | 1/5 |
752 | male | 8 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
752 | female | 8 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
188 | male | 2 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
188 | female | 2 | 0/5 | 0/5 | 0/5 | 1/5 | 1/5 |
23.5 | male | 0.5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
23.5 | female | 0.5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
The application of the test substance caused systemic toxicity, including mortality, in a dose dependent manner.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Remarks:
- Criteria used for interpretation of results: EU-GHS
- Conclusions:
- The application of the test substance caused systemic toxicity, including mortality, in a dose dependent manner.
- Executive summary:
In an acute oral study a test group consisting of 5 animals/sex was treated by single gavage application with an aqueous solution of MMEA (BASF AG, 1965, XV/126). The animals were observed for mortality and for clinical symptoms of toxicity. At the end of the observation period of 14 days, the surviving animals were sacrificed for the purpose of necropsy; animals that died during the observations period also were subjected to necropsy. The LD50 value was estimated on the basis of the observed mortalities.
At low doses (23.5 188 and 752 mg/kg bw), calm behavior was observed by treated animals. Dyspnoea, chewing compulsion, partially calm behavior occurred after application of 1504 mg/kg bw. After 24 h, crusted eyes and ruffled fur.
At high doses (1880, 2350 and 3008 mg/kg bw), dyspnoea, high stepping gait, staggering, smeared fur, diarrhea, calm behavior, chewing compulsions and gasping were observed. After 24 h squatting posture, ruffled fur, irregular accelerated respiration and abdominal position were still present. At 1880 mg/kg bw: 1 animal had distended ulceration with phlegmone and abscess of the entire glandular stomach and intestinal irritation. At the highest dose, intestinal atony was observed in one animal.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.